共 217 条
- [1] Bench AJ(2001)Myeloproliferative disorders Clin Haematol 14 531-51
- [2] Cross NCP(2005)A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 1779-90
- [3] Huntly BJP(2000)Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera Blood 95 2569-76
- [4] Kralovics R(2005)Serum in-terleukin (IL)-l, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases Br J Haematol 130 709-15
- [5] Passamonti F(2003)Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia Curr Hematol Rep 2 248-56
- [6] Buser AS(1991)Essential thrombocythemia in a child: management with anagrelide Am J Pediatr Hematol Oncol 13 52-6
- [7] Temerinac S(1995)Treatment of essential thrombocythemia with anagrelide J Pediatr 127 495-8
- [8] Klippel S(1998)Successful treatment of essential thrombocythemia with anagrelide in a child Med Pediatr Oncol 30 367-71
- [9] Strunck E(1998)Treatment of children with anagrelide for thrombocythemia J Pediatr Hematol Oncol 20 469-73
- [10] Panteli KE(2002)Current management of polycythemia vera Leuk Lymphoma 43 1-7